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INTRODUCTION
Sepsis and its complications continue to represent
a significant cause of mortality among hospitalized
patients. It includes a systemic inflammatory re-
sponse to infection and when associated with organ
dysfunction it is known as septic shock (1). Severe
sepsis and septic shock are the primary causes of
the multiple organ dysfunction syndrome (MODS)
and one of the common causes of deaths (2). Many
water soluble mediators with pro and anti- inflam-
matory actions such as interleukins (IL-6, IL-8, IL-
10) and tumour necrosis factor alpha (TNF-alpha)
appear to play a core role in sepsis. The disease
conditions are still frequently encountered condi-
tions in today’s hospital environment despite the
growing armamentarium of antibiotics. This per-
sistent high mortality rate is unacceptable as it is
ranked above stroke and myocardial infarction. Many
sepsis patients have at least one other dysfunction
and deaths are often attributed to these conditions
rather than to sepsis (3, 4). Possible reasons for this
high mortality is late recognition and inappropriate
treatment before entering the intensive care unit.
Sepsis is also a very complex disease state com-
plicated by heterogeneous presentation. Hypergly-
cemia and insulin resistance are common in critically
ill patients even without having had diabetes. Hyper-
glycemia or relative insulin deficiency or both dur-
ing critical illness may directly or indirectly confer a
predisposition to complications (5, 6) such as mul-
tiple organ failure and death. It has been shown that
intensive insulin therapy to maintain the blood glu-
cose at or below 110mg per deciliter reduces mor-
bidity and mortality among critically ill patients (5).
Gram positive organisms, malarial parasite fungi
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and endotoxin containing organisms can trigger sep-
sis. Bacteremia or endotoxin can stimulate the in-
nate immune system, endothelial cells and other
cells (7). Hyperglycemia increases the production
of reactive oxygen species inside aortic endothelial
cells and is known to be proinflammatory. It is likely
that glucose stimulates the production of TNF-
alpha, a potent proinflammatory molecule, which
is capable of activating NADPH dependent oxidase,
enhances nuclear factor kappa B (NFκB) and in-
tracellular cell adhesion molecule-1 (ICAM-1) ex-
pression. The stimulated cells release interleukins
and TNF-alpha which have profound effects on the
cardiovascular system, kidneys, liver, central nerv-
ous system and coagulation cascade (8). It is re-
ported that interleukin-8 is the most potent one
that is rapidly produced in the lung well before the
recruitment of the polymorphonuclear leucocytes.
The use of enteral glutamine supplementation in
critical illness is well established. Although there
was no statistical differences in mortality between
the glutamine supplemented versus non-supple-
mented patients, there was evidence that glutamine
reduced the incidence of pneumonia, sepsis and
bacteremia (9 - 12). It has been shown that glu-
tamine therapy caused attenuation of the inflam-
matory interleukins and enhanced expression of
heat shock proteins (13). Since heme oxygenase-1
(HO-1) is an inducible stress protein, which con-
fers cytoprotection against oxidative stress in vitro
and in vivo (14), we also included the measure-
ment of HO-1 in our model. Our aim is to establish
an in vitro model with the human umbilical cord
endothelial cells and test whether glutamine and
insulin used individually or together are cytopro-
tective in reducing proinflammatory responses in
cells which have been triggered by hyperglycaemia.
MATERIALS AND METHODS
Cell culture
Endothelial cells were obtained from Vec Tech-
nologies Inc, New York. Frozen cells were unpacked
immediately and stored in liquid nitrogen until
ready to use. When ready for culture the vials were
thawed at 37. When thawed the cells were trans-
ferred into T-25 flask coated with 50μg/ml of fi-
bronectin and the cells were immersed in 5 ml of
complete medium (MCDB-B-1). The cells were
incubated at 37and 5% CO2. After 12 to 18 hrs
when the cells were attached, the media were
changed every two hrs until the cells reached con-
fluency. At confluence, the cells were trypsinised,
counted and aliquoted into different vials and frozen.
Cell treatment
The frozen vial was removed and passaged.
When the flask reached confluency, the cells were
trypsinised and counted. 105 cells were added to
each flask and different concentrations of glucose
ranging from normal values (5.6 mM) to hypergly-
cemic levels (10 mM and 20 mM) were added to
each individual flask. The hyperglycemic flasks
(glucose concentration 20 mM) were divided into
3 groups. In the first group different concentra-
tions (40 mM)) of glutamine were added. In the
second group, insulin (1.0 10-12, 110-9, 110-6
units/ml) were added alone. In the third group
glutamine and insulin were added and the flasks
were incubated for the required length of time
(7 days). Cell were harvested and frozen until re-
quired for analysis of TNF-alpha and HO-1 while
culture media was retained for IL-8 analysis.
Measurement of TNF-alpha and HO-1 expression
Frozen cells were thawed and resuspended in 200
μl PBS. They were then lysed by using Lysis Buffer
and vortexed for 15 s. Total mRNA was extracted us-
ing Roche High Pure RNA isolation kit (Roche Daig-
nostics, Mannheim). Messenger RNA (mRNA) was
then converted to complementary DNA (cDNA).
The cDNA was converted to double stranded DNA
using Transcriptor First Strand cDNA synthesis kit
(Roche Diagnostics, Mannheim) and TNF-alpha
and HO-1 specific sense primer. TNF-alpha and
HO-1 cDNA were then amplified by TNF-alpha spe-
cific primer set (TNF-alpha-F : 5’ cag agg gcc tgt
acc tca tc ; TNF-alpha-R : 5’ gga aga ccc ctc cca gat
ag) and HO-1 primer set (HO-1-F : 5’ tct ctt ggc tgg
ctt cct ta ; HO-1-R : 5’ ggc cgt gtc aac aag gat ac)
respectively using Fast Start DNA Master SYBR
Green I kit (Roche Diagnostics, Mannheim) and
quantified using Roche LightCycler (15). The for-
mula (16) used for calculation of the relative quan-
tity is as follows : Ratio = (Etarget)CPtarget(control-sample)/
(Eref)CPref(control-sample)
Measurement of IL-8
Cytokine concentrations in the cell culture media
were determined using sandwich ELISA for IL-8
(17). Briefly, 96 -well immunomaxisorb plates
(Nunc, Roskilde) were coated overnight at 4
with cytokine specific mAb. TNF-alpha in the su-
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pernatant was detected with polyclonal rabbit anti-
human TNF-alpha followed by peroxidase conju-
gated, goat anti-rabbit IgG (Jackson Immunore-
search Laboratories, Westgrove). IL-8 was detected
by biotinylated polyclonal rabbit anti-human IL-8
followed by peroxidase -conjugated streptavidin. Te-
tramethylbenzidine was used as a substrate for per-
oxidase and spectrophotometry was performed at
450 nm.
RESULTS
Under hyperglycemic conditions (20 mM) the ex-
pression of IL - 8 was 1.2 times higher than under
normal glucose levels. In hyperglycemic conditions,
when the cells were treated with 40 mM of glu-
tamine or insulin, the IL-8 level was not reduced
significantly (p0.05). In hyperglycemic cells treated
with the highest concentration of insulin (10-6 M)
and glutamine (40 mM) together, the IL-8 level
was reduced by 2 times, p0.001 (Fig. 1). Under
the same hyperglycemic conditions the expression
of HO-1 was 2.7 times higher than under normal
glucose levels (Fig. 2). This is in agreement with
the fact that HO-1 is an inducible stress protein.
This experiment clearly demonstrates that HO-1 is
largely produced under stress of hyperglycaemia.
In hyperglycemic cells treated with 40 mM of glu-
tamine or 10-6 M insulin, the HO-1 level was re-
duced 3.2 times and 6.4 times respectively. In the
cells treated with insulin and glutamine together
the HO-1 level was reduced 5.1 times even at the
lowest concentration of ether insulin or glutamine.
Under the same conditions, the expression of TNF-
alpha was 3 times higher than under normal glu-
cose level (Fig. 3). In hyperglycemic cells treated
with 40 mM of glutamine or 10-6 M insulin, the
TNF-alpha level was reduced about 5.7 times and
6.3 times respectively. In hyperglycemic cells treated
with insulin and glutamine together, the TNF-alpha
level was reduced 3.8 times at the lowest concen-
tration of ether glutamine or insulin.
Fig. 1. Determination of endothelial IL-8 levels under different treatment conditions. IL-8 levels were measured by sandwich ELISA.
Fig. 2. Determination of endothelial TNF-alpha expression under different treatment conditions. Values are means of triplicates
experiments. Expression was measurede by real-time PCR.
Fig. 3. Determination of endothelial HO-1 expression under different treatment conditions. Values are means of triplicate experi-
ments. Expression was measured by real-time PCR.
S. Muniandy, et al. Inflammatory process in endothelial cells8
DISCUSSION
It has been hypothesized that hyperglycemia or
relative insulin deficiency or both during critical
illness may directly or indirectly confer a predispo-
sition to complications (18, 19) such as severe in-
fections, polyneuropathy, multiple organ failure and
death. It has been shown that intensive insulin ther-
apy to maintain the blood glucose at or below 110
mg/dl reduces morbidity and mortality among criti-
cally ill patients (18). Gram positive organisms, ma-
larial parasites, fungi and endotoxin containing or-
ganisms can trigger sepsis. The invading organ-
isms proliferate and produce bacteremia or may re-
lease endotoxin that stimulates the innate immune
system, endothelial cells and other cells (7). These
stimulated cells release proinflammatory interleuk-
ins like IL-8, TNF-alpha, endorphins, nitric oxide,
and migration inhibitory factor (MIF) which in
turn augment the expression of various adhesion
molecules.
In order to test this hypothesis and the mecha-
nism involved in the predisposition to complications
under hyperglycemic conditions we set up an in
vitro model with endothelial cells. The endothelial
cells were subjected to hyperglycemic conditions
to test the effect hyperglycemia on the endothelial
cells with respect to the production of IL-8, TNF-
alpha and HO-1.
It is known that hyperglycemia increases the pro-
duction of reactive oxygen species in aortic endo-
thelial cells and is known to be proinflammatory.
What could be the mechanisms by which glucose
stimulate proinflammmatory events? It is likely that
glucose stimulates the production of TNF-alpha, a
potent proinflammatory molecule which is capable
of activating the NADPH dependent oxidase, en-
hances NFκB activity and ICAM-1 expression (20).
This ability of glucose to stimulate TNF-α produc-
tion, formation of free radicals, the expression of
adhesion molecules and suppression of nitric ox-
ide (NO) generation could be responsible for in-
creased morbidity, increased mortality and the high
incidence of sepsis and septic shock in diabetes
mellitus. In contrast to glucose, insulin suppresses
NFκB expression, free radical generation especially
superoxide, MIF production and enhances NO gen-
eration and inhibits inflammatory processes (21).
Furthermore, it has been shown that advanced gly-
cation endproducts produced during oxidative stress
of hyperglycaemia upregulate expression of vascu-
lar endothelial growth factor, tissue factor and the
proinflammatory cytokines TNF-alpha and IL-8 ac-
cording to length of stimulation.
A tight control of hyperglycemia with insulin and
the parenteral administration of the semi-essential
amino acid, glutamine have been shown to improve
the outcome of critically ill patients (22). Our re-
sults demonstrate that when endothelial cells were
made hyperglycemic, they expressed a large amount
of the heat shock protein HO-1 which was reduced
when cells were treated with insulin or a combina-
tion of insulin and glutamine. Our results shows
that at the cellular level insulin and glutamine at-
tenuated the expression of inflammatory cytokines,
such as TNF-alpha and IL-8, and reduced the oxi-
dative stress of hyperglycemia. Along with it, our
results also demonstrate that when endothelial cells
are treated with both insulin and glutamine to-
gether, the reduction in the inflammatory process
was far more effective than when treated with either
of them alone. Thus, when used in combination in-
sulin and glutamine may be therapeutically benefi-
cial for patients who present with sepsis.
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